Neoadjuvant Pembrolizumab Plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Nationwide Retrospective Turkish Oncology Group Study

Thumbnail Image

Tarih

2024

Yazarlar

Süreli Yayın başlığı

Süreli Yayın ISSN

Cilt Başlığı

ISSN

Cilt

Sayı

Yayınevi

MDPI

Özet

Açıklama

Anahtar kelimeler

triple\\-negative breast cancer, neoadjuvant therapy, pembrolizumab, pathological complete response, real world, event\\-free survival, overall survival, safety

Alıntı

URI

https://openaccess.acibadem.edu.tr/handle/11443/5547

Koleksiyonlar

WOS

Endorsement

Review

Supplemented By

Referenced By